Key result
Extracellular vesicles emerge as potential diagnostic and prognostic biomarkers and biological effectors in chronic cardiovascular diseases, including peripheral arterial disease, aortic stenosis, and aortic aneurysms.
Why the study?
The role of extracellular vesicles in the pathogenic mechanisms of cardiovascular remodeling remains to be completely deciphered, prompting review of their potential translational application to the diagnosis and therapy of chronic cardiovascular diseases.
Extracellular vesicles are emerging as promising diagnostic and prognostic biomarkers, as well as potential therapeutic targets, in chronic cardiovascular diseases involving vascular and valvular remodeling.
Hypothesis-generating for extracellular vesicle biomarkers in vascular diseases; leaves open clinical adoption pending prospective validation.
Cardiovascular diseases (CVDs) are the first cause of death worldwide. In recent years, there has been great interest in the analysis of extracellular vesicles (EVs), including exosomes and microparticles, as potential mediators of biological communication between circulating cells/plasma and cells of the vasculature. Besides their activity as biological effectors, EVs have been also investigated as circulating/systemic biomarkers in different acute and chronic CVDs. In this review, the role of EVs as potential diagnostic and prognostic biomarkers in chronic cardiovascular diseases, including atherosclerosis (mainly, peripheral arterial disease, PAD), aortic stenosis (AS) and aortic aneurysms (AAs), will be described. Mechanistically, we will analyze the implication of EVs in pathological processes associated to cardiovascular remodeling, with special emphasis in their role in vascular and valvular calcification. Specifically, we will focus on the participation of EVs in calcium accumulation in the pathological vascular wall and aortic valves, involving the phenotypic change of vascular smooth muscle cells (SMCs) or valvular interstitial cells (IC) to osteoblast-like cells. The knowledge of the implication of EVs in the pathogenic mechanisms of cardiovascular remodeling is still to be completely deciphered but there are promising results supporting their potential translational application to the diagnosis and therapy of different CVDs.
No takes yet. Share an insight, caveat, or question.
Martı́n-Ventura et al. (2022) conducted a review in Chronic Cardiovascular Diseases. Extracellular vesicles was evaluated. Extracellular vesicles emerge as potential diagnostic and prognostic biomarkers and biological effectors in chronic cardiovascular diseases, including peripheral arterial disease, aortic stenosis, and aortic aneurysms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: